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Purpose or Objective: The strong directional characteristics 
of step-and-shoot IMRT beams, and the ability to turn off the 
beam between segments, may be used to advantage when 
avoiding critical structures. Consequently, there may be a 
benefit in delivering selected parts of VMAT plans using IMRT 
beams. This study investigates such a hybrid approach for the 
case of prostate radiotherapy. 
 
Material and Methods: Five prostate patients were 
retrospectively studied. The AutoBeam treatment planning 
system produced hybrid IMRT / VMAT plans with a prescribed 
mean dose of 74 Gy in 37 fractions to the smallest of three 
target volumes, PTV74Gy, PTV71Gy and PTV60Gy. Inverse 
planning consisted of fluence optimisation using iterative 
least squares, sequencing, and aperture optimisation. The 
plans consisted of a single 220º arc with 111 segments 
arranged in groups of 20°. For each patient, five hybrid IMRT 
/ VMAT plans were constructed, with 0%, 25%, 50%, 75% and 
100% of the segment groups sequenced for IMRT, 
respectively, and the remainder of the segment groups 
sequenced for VMAT, maintaining the same number of beam 
segments in all cases. Thus, 0% IMRT corresponded to 
conventional VMAT and 100% IMRT corresponded to an 11-
beam IMRT plan. IMRT groups were selected on the basis of 
fluence variation in each group, the most complex fluence 
maps being selected for IMRT delivery at the central gantry 
angle of the group. Treatment plans were evaluated in terms 
of PTV dose uniformity (root-mean-square variation) and 
coverage, critical structure dose, objective value and 
monitor units. All plans were then delivered as single hybrid 
beams to a water-equivalent phantom using an Elekta 
Synergy accelerator with Agility head, and the delivery time 
recorded. The dose measured using a Farmer ionisation 
chamber at the centre of the phantom within PTV74Gy was 
compared with the planned dose. Data were demonstrated by 
quantile-quantile plots to be normally distributed and 
compared to the 0% IMRT case using paired Student t-tests. 
 
Results: All plans are clinically acceptable, but increasing the 
IMRT percentage improves PTV coverage (p < 0.01 for 50% or 
more), reduces the volume of rectum irradiated to 65 Gy (p < 
0.01) and increases the monitor units (p < 0.001) (Table 1). 
Delivery time also increases substantially, which is clinically 
relevant due to prostate motion being partly dependent on 
treatment time. All plans show accurate delivery of dose. 
.  
 
Conclusion: Hybrid IMRT / VMAT can be efficiently planned 
and delivered as a single beam sequence. Beyond 25% IMRT, 
the delivery time becomes unacceptably long, outweighing 
the benefit of the improved plan quality, but 25% IMRT is an 
attractive compromise. These hybrid plans can be accurately 
delivered. 
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Purpose or Objective: Dynamic Wave Arc (DWA) is a clinical 
approach designed to maximize the versatility of Vero SBRT 
system by synchronizing the gantry-ring noncoplanar 
movement with D-MLC optimization. The purpose of this 
study was to verify the delivery accuracy of DWA approach 
for SBRT treatments and to evaluate the potential dosimetric 
benefits. 
 
Material and Methods: A preclinical version of RayStation 
v4.7 (RaySearch Laboratories, Sweden) was used to create 
patient specific wave arc trajectories. DWA is an extended 
form of VMAT with a continuous varying ring position. The 
main difference in the optimization modules of VMAT and 
DWA is during the angular spacing, where the DWA algorithm 
does not consider the gantry spacing, but only the Euclidian 
norm of the ring and gantry angle that cannot exceed 4°. 
Thirty-one patients with various anatomical tumor regions 
were selected from the Vero patient database. It was 
decided to select some pathologies with a high incidence 
(prostate and oligometastases) and some more challenging 
cases from the perspective of organ-at-risk sparing i.e. 
centrally-located non-small cell lung cancer (NSCLC) tumors 
and locally-advanced pancreatic cancer (LAPC). DWA was 
benchmarked against the current clinical approaches and 
coplanar VMAT to establish the clinical importance of DWA 
among other treatment approaches. Each plan was evaluated 
with regards to the target coverage, dose to OAR, MU 
efficiency and treatment delivery time. The delivery 
accuracy was evaluated using the Delta4 2D diode array that 
takes in consideration the multi-dimensionality of DWA. 
 
Results: For prostate and oligometastases, the results 
showed that all modalities provide comparable plan quality, 
with no significant difference for PTV coverage or OAR 
sparing, but with a steeper dose gradient outside the target 
for DWA. The delivery time per lesion was significant reduced 
with DWA (Table 1). For centrally-located NSCLC (Figure 1), 
DWA and VMAT increased target coverage and conformity. 
The structures that significantly benefited from using DWA 
were proximal bronchus (Dmax 24.72Gy, 20.57Gy and 
22.75Gy) and esophagus (16.6Gy, 12.57Gy and 14.76Gy) for 8-
10CRT beams, DWA and VMAT, respectively. The other OARs 
presented comparable values. In the LAPC cases, DWA 
achieved similar PTV coverage, along with a significantly 
improved GTV coverage and improved low dose spillage 
(p<0.01). The delivery time and the number of MU needed to 
deliver the dose were significantly lower for DWA versus 
IMRT. The DWA plans presented a good agreement between 
measured and calculated dose, with an mean ɣ (3%,3mm) 
passing rate of 98.17%, 98.72%, 99.2% and 98.1% for the 
prostate, oligometatstatic cases, centrally-located NSCLC and 
LAPC, respectively. 
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Conclusion: DWA combines direct machine parameter 
optimization with noncoplanar geometry, allowing additional 
flexibility in dose delivery, while preserving dosimetrically 
robust delivery. 
 
Proffered Papers: RTT 5: Optimizing treatment planning 
and delivery in the pelvic region  
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Purpose or Objective: Radiotherapy treatment for cervical 
cancers typically involves external beam irradiation to the 
whole pelvis followed by an intra-uterine brachytherapy 
boost to the primary tumour site. The purpose of the current 
study was 1) to assess dose reduction to OARs using a VMAT 
treatment technique compared to a conformal four field 
brick and 2) whether VMAT using sequential or simultaneous 
integrated boost can provide coverage to the tumour and 
OARs similar to brachytherapy. 
 
Material and Methods: Ten patients previously treated for 
cervical cancer were identified (age range 30-78 years). Four 
plans were retrospectively produced for each patient (3D 
conformal four field brick, VMAT to the whole pelvis, VMAT 
boost, SIB) providing a phase one dose of 50.4Gy over 28 
fractions. The sequential boost dose varied between patients 
from 16.5Gy-27.5Gy over 3-5 fractions. An averaged boost 
dose of 31Gy over 32 fractions, corrected using biological 
equivalent dose calculations was used for all SIB plans. All 
data was corrected to EQD2.  
 
Figure1: Typical dose distribution for a VMAT with SIB plan. 
 
 
 
Results: Results demonstrated significantly improved dose 
homogeneity between the VMAT and four field phase one 
techniques (p<0.01) but failed to find significant dose 
reductions to the bladder and rectum. Dose to the bowel was 
reduced at all dose points (p<0.01). Comparing the VMAT and 
brachytherapy boost, significantly increased doses to OARs 
were identified in the VMAT boost (bladder p<0.05; rectum 
p<0.01; bowel p<0.01). Dose homogeneity was decreased 
using an SIB compared to sequential but OAR doses were also 
decreased (p<0.05).  
Table 1: Mean and standard deviation of OAR data contained 
within the SIB and VMAT phase one plus either boost or 
brachytherapy plan combinations. 
 
 
 
Conclusion: When treating cervical cancer, VMAT allowed 
significant improvement in dose homogeneity with overall 
reductions in doses to OARs. When comparing the feasibility 
of SIB or sequential EBRT boost instead of brachytherapy the 
SIB plan produced a better solution with respect to OAR 
doses. Whilst cervical surface doses with SIB to the high-risk 
CTV will not match brachytherapy a SIB may offer an 
alternative option for those patients who refuse/cannot 
access brachytherapy. 
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